Who invested in Avalyn Pharma

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$100Mraised across 1 round since 2025, from 1 source

Latest round: Series D, $100MJul 2025
Investors: 5

See who backed them

The rounds

Jul 2025
Series D$100M
Source recorded

Founders and team

From Avalyn Pharma's own website and the SEC filings it signed: 6 on the team.

Lyn BaranowskiChief Executive Officer
Jill DenningSenior Vice President, Clinical Development Operations
Jim BishopSenior Vice President, Business Operations
Doug CarlsonChief Financial Officer and Chief Business Officer
Adam GoldenGeneral Counsel and Head of Business Development
Heather TurnerBoard Chair

On the board, as filediCassandra Gianna LucaJonathan LeffKetan PatelNiall O'DonnellPeter MoldtTiba Aynechi

Everyone who backed them

Norwest Venture PartnersVC firm1round

Wellington ManagementVC firm1round

Perceptive AdvisorsAsset manager1round

Novo HoldingsVC firm1round

Catalio Capital ManagementVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 5 firms list Avalyn Pharma as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Andera PartnersPrivate equity2017, per its site

Global Source Ventures, LLCVC firmPer its own site

InVivium CapitalVC firmPer its own site

Vida VenturesVC firmPer its own site

XontogenyAcceleratorPer its own site

Quick answers about Avalyn Pharma

Who invested in Avalyn Pharma?

Avalyn Pharma's investors include Norwest Venture Partners, Wellington Management, Perceptive Advisors, Novo Holdings and Catalio Capital Management.

How much has Avalyn Pharma raised?

Avalyn Pharma has raised $100M across 1 round since 2025.

When did Avalyn Pharma last raise?

Avalyn Pharma's most recent round was a Series D of $100M in Jul 2025.

What was Avalyn Pharma's biggest round?

Its most recent round, $100M in Jul 2025, is also its largest on record.

Who backed Avalyn Pharma first?

Avalyn Pharma's first round on record, in Jul 2025, was backed by Norwest Venture Partners, Wellington Management and Perceptive Advisors and 2 others.